glp-1 induced gastroparesis Diabetic Gastroparesis: Principles and Current Trends in Management | Diabetes Therapy June Blog Post: T2DM Management

Oct 27: Coherus BioSciences and Shanghai Junshi Biosciences won approval Friday for Loqtorzi (toripalimab-tpzi)in combination with cisplatin and gemcitabinefor the first-line treatment of metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC)

A recent review has highlighted a number of dermatological effects, rare but significant, including hypersensitivity reactions, fat inflammation (panniculitis), bullous pemphigoid, and measles-like (morbilliform) drug eruptions [3] that may occur with their use

Yalda Olcott Head of Healthcare Operations Yalda holds a Doctor of Pharmacy degree from North Dakota State University and brings over a decade of pharmacy leadership experience, including retail pharmacy, medication therapy management (MTM), and pharmacy benefits management (PBM)

Not everyone needs electrolyte supplements daily, but many GLP-1 users benefit from having them as part of their routine

Calling Cipla a big ethical Indian multinational with strong values, Dr Kovil added that the partnership is synergistic for both companies and beneficial for patients at large. Winselow Tucker, President and General Manager of Lilly India, said that the collaboration aligns with Lillys mission to make life better for people around the world by accelerating access to innovative medicines in underserved communities

However, real-world use reveals higher reported anxiety incidence in some populations, suggesting trial populations may not fully represent all users or that symptom severity goes underreported in structured settings